No insider open-market trades in 90 days (SEC Form 4). Congress: no trades disclosed in 180 days.
Analyst target and ratings are on paid plans
See the 12-month consensus target and the buy/hold/sell rating split.
Unlock the full results8 funds hold a position.
Top-trader positions in SPWH could not be loaded.
Hyperliquid positioning - not every stock is covered
Last report
Sep 1, 2026
Period ending
Aug 1, 2026
Earnings per share
-$0.11 expected
| Period ending | Reported | EPS / estimate | EPS surprise | Revenue / income | Surprise |
|---|---|---|---|---|---|
| Aug 1, 2026 | Sep 1, 2026 | -$0.08 / -$0.11Alpha Vantage | +27.27% beat | $295.6M No estimateSEC filing | Unavailable |
| May 2, 2026 | Jun 2, 2026 | -$0.39 / -$0.58Alpha Vantage | +32.76% beat | $256.1M No estimateSEC filing | Unavailable |
| Jan 31, 2026 | Mar 31, 2026 | -$0.10 / -$0.18Alpha Vantage | +45.05% beat | $1.21B No estimateYear ended Jan 31, 2026 · SEC filing | Unavailable |
| Nov 1, 2025 | Dec 4, 2025 | $0.08 / $0.08Alpha Vantage | +$0.00 in line | $331.3M No estimateSEC filing | Unavailable |
| Aug 2, 2025 | Sep 4, 2025 | -$0.12 / -$0.12Alpha Vantage | +0.00% in line | $293.9M No estimateSEC filing | Unavailable |
| May 3, 2025 | Jun 3, 2025 | -$0.41 / -$0.47Alpha Vantage | +12.77% beat | $249.1M No estimateSEC filing | Unavailable |
| Jan 31, 2025 | Apr 1, 2025 | $0.04 / -$0.06Alpha Vantage | +$0.10 beat | $1.20B No estimateYear ended Feb 1, 2025 · SEC filing | Unavailable |
| Nov 2, 2024 | Dec 10, 2024 | $0.04 / -$0.02Alpha Vantage | +$0.06 beat | $324.3M No estimateSEC filing | Unavailable |
EPS uses Yahoo Finance where available, then Alpha Vantage or verified release comparisons. Revenue and income use company releases, SEC filings, Alpha Vantage or Yahoo Finance. Non-USD revenue carries its currency code. Comparisons require a paired release estimate.
This company is not yet profitable.
Valuation
Quality
Growth
This stock is under pressure.
Trend
Under pressure
0 / 100
RSI 14
20D volatility
52-week range
20D support
20D resistance
Returns
Price vs moving averages
Volume pace